Charles River Laboratories | CRL - Trade Creditors

Stock Price
167.56
Daily Change
1.50 0.90%
Monthly
-24.64%
Yearly
-0.24%
Q1 Forecast
163.68

Charles River Laboratories reported $148.8M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Agilent USD 570M 40M Sep/2025
Align Technology USD 121.45M 4.1M Dec/2025
Bio-Rad Laboratories USD 129M 200K Dec/2025
Bruker USD 215.9M 31.5M Dec/2025
Cardinal Health USD 39B 2.14B Dec/2025
Charles River Laboratories USD 148.8M 20.82M Dec/2025
Cigna USD 9.35B 592M Sep/2025
Concord Medical Services Hldg CNY 131.59M 15.16M Jun/2023
CVS Health USD 59.38B 1.56B Dec/2025
Danaher USD 1.84B 147M Dec/2025
Dentsply International USD 268M 0 Sep/2025
Elevance Health USD 17.08B 64M Dec/2025
Galapagos EUR 100.63M 32.55M Sep/2025
Hologic USD 201.1M 573.5M Dec/2025
Humana USD 5.72B 198M Dec/2025
Illumina USD 240M 22M Dec/2025
Incyte USD 1.63B 1.46B Dec/2025
Intrexon USD 4.85M 3.12M Jun/2024
IQVIA Holdings USD 3.75B 201M Dec/2025
Laboratory Of America USD 840.8M 172.3M Dec/2025
Lonza CHF 471M 3M Dec/2024
McKesson USD 60.68B 255M Dec/2025
Merck EUR 1.93B 32M Sep/2025
Mettler Toledo International USD 266.63M 19.22M Dec/2025
Novartis USD 4.56B 49M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Quest Diagnostics USD 1.6B 143M Dec/2025
Revvity USD 185.46M 9.66M Dec/2025
Thermo Fisher Scientific USD 3.12B 140M Sep/2025
United Therapeutics USD 7.1M 460.9M Dec/2025
UnitedHealth USD 40.18B 1.75B Sep/2025
Veradigm USD 12.61M 5.4M Sep/2022
Waters USD 103.78M 11.95M Dec/2025
West Pharmaceutical Services USD 253.7M 2.1M Dec/2025